• 30632 Citations
  • 94 Scopus h-Index
19962020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Rafael Fonseca is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 26 Similar Profiles
Multiple Myeloma Medicine & Life Sciences
Waldenstrom Macroglobulinemia Medicine & Life Sciences
Plasma Cells Medicine & Life Sciences
Dexamethasone Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Survival Medicine & Life Sciences
Monoclonal Gammopathy of Undetermined Significance Medicine & Life Sciences
Thalidomide Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2000 2020

Multiple Myeloma
Oncolytic Virotherapy
Clonal Evolution
Vesicular Stomatitis
Research

Specialized Program of Research Excellence in Myeloma

Fonseca, R., Bergsagel, L., Hideshima, T., Kufe, D. W., Anderson, K. C., Munshi, N. C., Kufe, D. W., Cozen, W., Munshi, N. C., Anderson, K. C., Weller, E., Bradner, J., Munshi, N. C. & C.Anderson, K.

National Institutes of Health

9/1/038/31/18

Project: Research project

Plasma Cell Neoplasms
Multiple Myeloma
Research Personnel
Waldenstrom Macroglobulinemia
Comparative Genomic Hybridization
Chromosome Aberrations
Multiple Myeloma
Fluorescence In Situ Hybridization
Chromosomes, Human, Pair 13
Thalidomide

Research Output 1996 2019

Citron Rho-interacting kinase silencing causes cytokinesis failure and reduces tumor growth in multiple myeloma

Sahin, I., Kawano, Y., Sklavenitis-Pistofidis, R., Moschetta, M., Mishima, Y., Manier, S., Sacco, A., Carrasco, R., Fonseca, R., Roccaro, A. M., Witzig, T. E. & Ghobrial, I. M., Apr 9 2019, In : Blood Advances. 3, 7, p. 995-1002 8 p.

Research output: Contribution to journalArticle

Open Access
Cytokinesis
Multiple Myeloma
Growth
Neoplasms
Protein-Serine-Threonine Kinases
1 Citation (Scopus)

Incidence of skeletal-related events among multiple myeloma patients in the United States at oncology clinics: Observations from real-world data

Kim, C., Bhatta, S., Cyprien, L., Fonseca, R. & Hernandez, R. K., Feb 1 2019, In : Journal of Bone Oncology. 14, 100215.

Research output: Contribution to journalArticle

Multiple Myeloma
Incidence
History
Proteasome Inhibitors
Electronic Health Records

Monoclonal antibody utilization characteristics in patients with multiple myeloma

Ailawadhi, S., Sher, T., Azzouqa, A. G., Meghji, Z., Jain, T., Jani, P., Ahmed, S., Diehl, N., Roy, V., Shah, V., Hodge, D., Ailawadhi, M., Alegria, V. R., Paulus, A., Chanan Khan, A. A. & Fonseca, R., Sep 1 2019, In : Anti-cancer drugs. 30, 8, p. 859-865 7 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Monoclonal Antibodies
Premedication
Clinical Trials
Drug Utilization

MYC dysregulation in the progression of multiple myeloma

MMRF CoMMpass Network, Jan 1 2019, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalLetter

Multiple Myeloma
1 Citation (Scopus)

Review of the patient-centered communication landscape in multiple myeloma and other hematologic malignancies

LeBlanc, T. W., Baile, W. F., Eggly, S., Bylund, C. L., Kurtin, S., Khurana, M., Najdi, R., Blaedel, J., Wolf, J. L. & Fonseca, R., Jan 1 2019, In : Patient Education and Counseling.

Research output: Contribution to journalReview article

Hematologic Neoplasms
Multiple Myeloma
Communication
Publications
Decision Making